TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36975195

Group type: EXPERIMENTAL
Intervention: 2-week MTM
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: 4-week MTM
Number of subjects: 650

Group type: COMPARATOR
Intervention: Comparison between 2-week and 4-week MTM
Number of subjects: 650
Study: 33486385

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral group therapy (CBGT)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Mindfulness‐based stress reduction (MBSR)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Waitlist control (WL)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral group therapy (CBGT) and Mindfulness‐based stress reduction (MBSR)
Number of subjects: 108
Study: 32761337

Group type: EXPERIMENTAL
Intervention: Guilingji Capsules (GLJC) 0.6 g once a day and 19.2 mg of Gingko biloba extract mimetic 3 times a day
Number of subjects: 348

Group type: COMPARATOR
Intervention: Guilingji Capsules (GLJC) mimetic 0.6 g once a day and 19.2 mg of Gingko biloba extract in tablet form 3 times a day
Number of subjects: 348
Study: 36161864

Group type: EXPERIMENTAL
Intervention: OMEGA group (n = 14; 2234 mg of EPA and 916 mg of DHA daily)
Number of subjects: 26

Group type: COMPARATOR
Intervention: MCT group (n = 12; 4000 mg of MCT daily)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Combined data from both groups
Number of subjects: 26
Study: 33368399

Group type: EXPERIMENTAL
Intervention: Selected radiomic features for larger lesions
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Combination of volume as predictor for smaller lesions and selected features for larger lesions
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Selected radiomic features for smaller lesions
Number of subjects: 150
Study: 32392748

Group type: EXPERIMENTAL
Intervention: Regular siesta practice
Number of subjects: 194

Group type: COMPARATOR
Intervention: Hypertension
Number of subjects: 194

Group type: COMPARATOR
Intervention: Diabetes mellitus
Number of subjects: 194

Group type: COMPARATOR
Intervention: Excess body weight (BMI > 25 kg/m2)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Dyslipidemia
Number of subjects: 194
Study: 36401615

Group type: EXPERIMENTAL
Intervention: Salvage surgery after locoregional failure (LRF)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Salvage surgery after LRF
Number of subjects: 61
Study: 32722652

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Combined Training (CT = HIIT + RT)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Nutritional Guidance (NG)
Number of subjects: 55
Study: 36206888

Group type: EXPERIMENTAL
Intervention: Imagery focussed cognitive therapy (ImCT)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Group psychoeducation (PE)
Number of subjects: 62
Study: 33942423

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy for insomnia (CBT-I)
Number of subjects: 276
Study: 34961942

Group type: EXPERIMENTAL
Intervention: 0.8% HA gel applied onto the collagen matrix three times per day for 7 days
Number of subjects: 38

Group type: COMPARATOR
Intervention: No gel application
Number of subjects: 38
Study: 32599670

Group type: EXPERIMENTAL
Intervention: 9-12 week exercise intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Waitlist-control group
Number of subjects: 30
Study: 34802922

Group type: EXPERIMENTAL
Intervention: ISBAR structured dialogue tool
Number of subjects: 50
Study: 33216408

Group type: EXPERIMENTAL
Intervention: CCT combined with tDCS targeting left dorsolateral prefrontal cortex (1 mA)
Number of subjects: 77

Group type: COMPARATOR
Intervention: CCT combined with sham tDCS (40s active stimulation, 1 mA)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: CCT combined with tDCS
Number of subjects: 77
Study: 34964449

Group type: EXPERIMENTAL
Intervention: SHED-IT: Recharge (n = 62)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Wait-list control (n = 63)
Number of subjects: 125
Study: 32242400

Group type: EXPERIMENTAL
Intervention: Plum-blossom needling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tropicamide eye drops
Number of subjects: 0
Study: 35320176

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour hypnotherapy (3 months duration)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 60
Study: 32748456

Group type: EXPERIMENTAL
Intervention: AAE form
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: EndoApp
Number of subjects: 206
Study: 36356411

Group type: EXPERIMENTAL
Intervention: PALLI-COM communication skills training (2 × 90 min)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: PALLI-COM communication skills training
Number of subjects: 141

Group type: COMPARATOR
Intervention: Wait list control group (CG)
Number of subjects: 141
Study: 32079526

Group type: EXPERIMENTAL
Intervention: PEEP individually titrated, guided by an analysis of the intratidal compliance profile
Number of subjects: 60

Group type: COMPARATOR
Intervention: PEEP 5 cmH2O (control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Comparison of respiratory mechanics and hemodynamic variables
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Compliance profile analysis
Number of subjects: 60
Study: 36396084

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (660nm, 400mW/cm2, 300 seconds, methylene blue 0.01%)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Mupirocin (twice a day for 5 days)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Mupirocin
Number of subjects: 34
Study: 34213868

Group type: EXPERIMENTAL
Intervention: CT navigation percutaneous spinal endoscopy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Open discectomy
Number of subjects: 68
Study: 35082136

Group type: EXPERIMENTAL
Intervention: Surgical Aortic Valve Replacement (SAVR)
Number of subjects: 291448

Group type: EXPERIMENTAL
Intervention: Transcatheter Aortic Valve Implantation (TAVI)
Number of subjects: 291448

Group type: COMPARATOR
Intervention: No intervention (proactive management)
Number of subjects: 291448
Study: 33074590

Group type: EXPERIMENTAL
Intervention: linagliptin 5 mg/d
Number of subjects: 206

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 206
Study: 32520140

Group type: EXPERIMENTAL
Intervention: Balloon catheter
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metal cannula
Number of subjects: 0
Study: 35484927

Group type: EXPERIMENTAL
Intervention: Starch- and sucrose-reduced diet (SSRD) for 4 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (habitual diet), n = 25
Number of subjects: 80
Study: 34542305

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/Salmeterol (FP/Salm) with as-needed short acting beta-2 agonist (SABA)
Number of subjects: 7787

Group type: COMPARATOR
Intervention: Budesonide/Formoterol (BUD/Form) Maintenance And Reliever Therapy (MART)
Number of subjects: 7787
Study: 33596833

Group type: EXPERIMENTAL
Intervention: High-sensitive cardiac troponin I (hs-cTnI) measurement at presentation
Number of subjects: 3295

Group type: EXPERIMENTAL
Intervention: High-sensitive cardiac troponin I (hs-cTnI) measurement
Number of subjects: 3295
Study: 32532631

Group type: EXPERIMENTAL
Intervention: Epidermal grafting (EG)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Split thickness skin grafting (SSG)
Number of subjects: 44
Study: 36102582

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided anterior quadratus lumborum block (LAL-QLB) with intravenous analgesia
Number of subjects: 74

Group type: COMPARATOR
Intervention: Thoracic epidural analgesia (TEA)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: LAL-QLB
Number of subjects: 74

Group type: COMPARATOR
Intervention: TEA
Number of subjects: 74
Study: 32505867

Group type: EXPERIMENTAL
Intervention: LED-based stimulation systems (FSA 10® and Lifeline® stimulators)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Grass PS 33 xenon lamp device
Number of subjects: 39
Study: 34626891

Group type: EXPERIMENTAL
Intervention: Internet dissonance-based intervention (DBI-I)
Number of subjects: 278
Study: 32548702

Group type: EXPERIMENTAL
Intervention: Diabetes-related autoantibodies (ICA, IAA, GADA, IA-2A, ZnT8A)
Number of subjects: 2159
Study: 35689673

Group type: EXPERIMENTAL
Intervention: Digital breast tomosynthesis (DBT)
Number of subjects: 73866
Study: 33035148

Group type: EXPERIMENTAL
Intervention: E-learning program (15-min duration)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 50
Study: 33130570

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (4×4 min at 75%-85% peak power output)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Moderate-intensity continuous training (25 min at 55%-65% peak power output)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Strength training (whole body, 3 sets of 6-12 repetitions at 70%-90% one repetition maximum)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual-care control group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 60
Study: 33654240

Group type: EXPERIMENTAL
Intervention: Ownership of home blood pressure monitor (HBPM)
Number of subjects: 21104

Group type: EXPERIMENTAL
Intervention: Being male
Number of subjects: 21104

Group type: EXPERIMENTAL
Intervention: Residing in a less deprived socioeconomic region (IMD Decile 6–10)
Number of subjects: 21104

Group type: EXPERIMENTAL
Intervention: History of diabetes mellitus
Number of subjects: 21104

Group type: EXPERIMENTAL
Intervention: Current smokers compared to non-smokers
Number of subjects: 21104
Study: 34130617

Group type: EXPERIMENTAL
Intervention: Direct angiographic intervention for selected patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Endovascular thrombectomy
Number of subjects: 0
Study: 32675229

Group type: EXPERIMENTAL
Intervention: myPlan Kenya (intervention)
Number of subjects: 352

Group type: COMPARATOR
Intervention: Standard IPV referrals (control)
Number of subjects: 352
Study: 34251949

Group type: EXPERIMENTAL
Intervention: Social media-based support via WhatsApp
Number of subjects: 68

Group type: COMPARATOR
Intervention: Routine breastfeeding teaching
Number of subjects: 68
Study: 34839993

Group type: EXPERIMENTAL
Intervention: PCV20
Number of subjects: 3

Group type: COMPARATOR
Intervention: PCV13
Number of subjects: 3

Group type: COMPARATOR
Intervention: PPSV23
Number of subjects: 3
Study: 35784225

Group type: EXPERIMENTAL
Intervention: Intervention approach 2 (FGD/KI and information on animal health)
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Intervention approach 3 (FGD/KII and information package on animal health plus information on AMR)
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Intervention meetings
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Female farmers
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Veterinary professionals
Number of subjects: 325
Study: 34049123

Group type: EXPERIMENTAL
Intervention: Assertiveness training only
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: SBAR technique only
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Combination of assertiveness training and SBAR technique
Number of subjects: 93
Study: 35279333

Group type: EXPERIMENTAL
Intervention: Health education via mobile applications
Number of subjects: 214

Group type: COMPARATOR
Intervention: Routine face-to-face education (Control)
Number of subjects: 214
Study: 34083388

Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: All three drugs
Number of subjects: 210
Study: 32909660

Group type: EXPERIMENTAL
Intervention: Lebrikizumab
Number of subjects: 64
Study: 34792871

Group type: EXPERIMENTAL
Intervention: IPT‐BPD‐R
Number of subjects: 43

Group type: COMPARATOR
Intervention: Waiting list with clinical management
Number of subjects: 43
Study: 34687986

Group type: EXPERIMENTAL
Intervention: Digital email adherence intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Overall adherence
Number of subjects: 30
Study: 36104740

Group type: EXPERIMENTAL
Intervention: eHealth intervention (ManGuard)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 30
Study: 35197082

Group type: EXPERIMENTAL
Intervention: Allopurinol (20 mg/kg, administered intravenously in 2 doses early postnatally and 3 doses perioperatively)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Mannitol-placebo (control group)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 236
Study: 32029498

Group type: EXPERIMENTAL
Intervention: 1500 mg TXA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 0
Study: 34298279

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study: 35000455

Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloons (DCB)
Number of subjects: 758

Group type: COMPARATOR
Intervention: Drug-Eluting Stents (DES)
Number of subjects: 758
Study: 33411845

Group type: EXPERIMENTAL
Intervention: Health behavior pattern 2 (alcoholic beverage and smoking habit)
Number of subjects: 71553

Group type: EXPERIMENTAL
Intervention: Health behavior pattern 3 (ultra-processed food and screen time)
Number of subjects: 71553

Group type: EXPERIMENTAL
Intervention: Health behavior pattern 1 (water, unprocessed and minimally processed food and physical activity)
Number of subjects: 71553

Group type: EXPERIMENTAL
Intervention: Regularly purchasing snacks in the school cafeteria
Number of subjects: 71553
Study: 33993205

Group type: EXPERIMENTAL
Intervention: ?‐3 carboxylic acid (CA)
Number of subjects: 13078

Group type: COMPARATOR
Intervention: corn oil
Number of subjects: 13078
Study: 36181071

Group type: EXPERIMENTAL
Intervention: High-pitch cervical CT (HP-CT)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Standard cervical CT (SD-CT)
Number of subjects: 95
Study: 32525328

Group type: EXPERIMENTAL
Intervention: MI-based interactive message
Number of subjects: 805

Group type: EXPERIMENTAL
Intervention: Noninteractive motivational message
Number of subjects: 805

Group type: COMPARATOR
Intervention: Control message (no motivational elements)
Number of subjects: 805
Study: 35672833

Group type: EXPERIMENTAL
Intervention: 9-month regimen for rifampicin-resistant tuberculosis
Number of subjects: 0

Group type: COMPARATOR
Intervention: 20-month regimen for rifampicin-resistant tuberculosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental regimens including bedaquiline (Stage 2 of STREAM)
Number of subjects: 0
Study: 32050305

Group type: EXPERIMENTAL
Intervention: Emotional barriers reported by participants
Number of subjects: 2360

Group type: EXPERIMENTAL
Intervention: Cancer symptom awareness score
Number of subjects: 2360
Study: 35978336

Group type: EXPERIMENTAL
Intervention: Pharmacist-led telehealth intervention in Hyperlink 1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmacist-led telehealth intervention in Hyperlink 3
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hyperlink 1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hyperlink 3
Number of subjects: 0
Study: 33544533

Group type: EXPERIMENTAL
Intervention: Surgical mask
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Respiratory mask
Number of subjects: 297
Study: 32614875

Group type: EXPERIMENTAL
Intervention: Telephone call from a midwife offering choice between a visit for a pap smear or an HPV self-sampling test
Number of subjects: 10614

Group type: EXPERIMENTAL
Intervention: HPV self-sampling test only
Number of subjects: 10614

Group type: COMPARATOR
Intervention: Routine procedure with a yearly invitation (Control)
Number of subjects: 10614

Group type: EXPERIMENTAL
Intervention: Follow-up after abnormality
Number of subjects: 10614

Group type: EXPERIMENTAL
Intervention: Non-attendees with study intervention
Number of subjects: 10614

Group type: COMPARATOR
Intervention: Non-attendees without study intervention (Control)
Number of subjects: 10614
Study: 36225762

Group type: EXPERIMENTAL
Intervention: Text4Hope intervention group (IG) receiving once-daily supportive text messages for 6 weeks
Number of subjects: 286

Group type: COMPARATOR
Intervention: Control group (CG) not receiving text messages
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Text4Hope intervention group (IG)
Number of subjects: 286
Study: 35968725

Group type: EXPERIMENTAL
Intervention: Palmar grasp reflex stimulation during bathing
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (standard tub bathing)
Number of subjects: 82
Study: 32897310

Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure reduction (goal, 110‐139 mm Hg)
Number of subjects: 999

Group type: COMPARATOR
Intervention: Standard systolic blood pressure reduction (goal, 140‐179 mm Hg)
Number of subjects: 999

Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure reduction
Number of subjects: 999

Group type: COMPARATOR
Intervention: Standard systolic blood pressure reduction
Number of subjects: 999
Study: 36199051

Group type: EXPERIMENTAL
Intervention: Biomechanical markers (e.g., flexion during loading)
Number of subjects: 0

Group type: COMPARATOR
Intervention: X-ray grading (Kellgren-Lawrence grade)
Number of subjects: 0
Study: 33913415

Group type: EXPERIMENTAL
Intervention: Intracorporeal anastomosis (ICA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Extracorporeal anastomosis (ECA)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both ICA and ECA
Number of subjects: 100
Study: 32854623

Group type: EXPERIMENTAL
Intervention: Suburban CHCs
Number of subjects: 2404

Group type: COMPARATOR
Intervention: Urban CHCs
Number of subjects: 2404

Group type: COMPARATOR
Intervention: Rural CHCs
Number of subjects: 2404
Study: 33837140

Group type: EXPERIMENTAL
Intervention: Invasive placebos (SHAM grades of 3 or more)
Number of subjects: 1494

Group type: COMPARATOR
Intervention: Non-invasive placebo
Number of subjects: 1494
Study: 35206449

Group type: EXPERIMENTAL
Intervention: Moderate–vigorous physical activity (MVPA)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Screen time
Number of subjects: 100
Study: 32207709

Group type: EXPERIMENTAL
Intervention: Standard treatment complex (STC) + 5% brine electrophoresis by sinusoidal modulated currents, sage and sea baths
Number of subjects: 83

Group type: COMPARATOR
Intervention: Standard treatment complex (STC)
Number of subjects: 83
Study: 35849214

Group type: EXPERIMENTAL
Intervention: Fast infusion of 20% albumin (3 mL/kg over 30 min)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Slow infusion of 20% albumin (3 mL/kg over 120 min)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fast infusion of 20% albumin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Slow infusion of 20% albumin
Number of subjects: 12
Study: 33537000

Group type: EXPERIMENTAL
Intervention: Letrozole (LE) 2.5mg/day
Number of subjects: 270

Group type: COMPARATOR
Intervention: Clomiphene Citrate (CC) 50mg/day
Number of subjects: 270

Group type: COMPARATOR
Intervention: Natural Cycle
Number of subjects: 270
Study: 35962633

Group type: COMPARATOR
Intervention: E. sinica at 1% (CEa1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: E. sinica at 3% (CEa2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: E. sinica at 5% (CEa3)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control treatment (CON)
Number of subjects: 0
Study: 34103066

Group type: EXPERIMENTAL
Intervention: Taurine supplementation (30 mg/kg/day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard Entera Meal
Number of subjects: 32
Study: 32103160

Group type: EXPERIMENTAL
Intervention: 30% oral dextrose
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: 30% oral dextrose and facilitated tucking
Number of subjects: 169

Group type: COMPARATOR
Intervention: Facilitated tucking
Number of subjects: 169
Study: 36401577

Group type: EXPERIMENTAL
Intervention: Amniotic membrane
Number of subjects: 34

Group type: COMPARATOR
Intervention: Platelet-rich fibrin
Number of subjects: 34
Study: 32844597

Group type: EXPERIMENTAL
Intervention: Three playful things
Number of subjects: 533

Group type: EXPERIMENTAL
Intervention: Using playfulness in a new way
Number of subjects: 533

Group type: EXPERIMENTAL
Intervention: Counting playfulness
Number of subjects: 533

Group type: COMPARATOR
Intervention: Placebo condition
Number of subjects: 533
Study: 36239405

Group type: EXPERIMENTAL
Intervention: Fulvestrant-Palbociclib (FP)
Number of subjects: 486

Group type: EXPERIMENTAL
Intervention: Letrozole-Palbociclib (LP)
Number of subjects: 486
Study: 32615179

Group type: COMPARATOR
Intervention: Very early precut (group A)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Primary precut (group B)
Number of subjects: 303
Study: 32376814

Group type: EXPERIMENTAL
Intervention: Physical activity promoting program based on the IMB model
Number of subjects: 75
Study: 32062862

Group type: EXPERIMENTAL
Intervention: Exenatide extended release 2 mg
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 34571011

Group type: EXPERIMENTAL
Intervention: Wii Fit rehabilitation program (30 minutes) in addition to standard physical therapy program (SPTP) (60 minutes), 3 sessions a week for 12 weeks.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard physical therapy program (SPTP) only, 3 sessions a week for 12 weeks.
Number of subjects: 34
Study: 32586078

Group type: EXPERIMENTAL
Intervention: Repetitions in reserve (RIR)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Maximum effort (RM)
Number of subjects: 14
Study: 35859360

Group type: EXPERIMENTAL
Intervention: Upper body stretching (n = 15)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Lower body power training (n = 33)
Number of subjects: 48
Study: 34480783

Group type: EXPERIMENTAL
Intervention: Baseline values of HRQoL, six-minute walking distance, Borg-score, coronary heart disease, SF-36 role-emotional
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Baseline values of Borg-score, six-minute walking distance, coronary heart disease, SF-36 vitality
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Baseline values of SF-36 physical functioning, HADS anxiety
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Baseline values of SF-36 vitality, presence of coronary heart disease
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Baseline values of HADS anxiety
Number of subjects: 422
Study: 32331793

Group type: EXPERIMENTAL
Intervention: Hepatic epithelioid angiomyolipoma (HEAML)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Non-hepatitis B, non-hepatitis C hepatocellular carcinoma (NBNC‐HCC)
Number of subjects: 66